BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22705067)

  • 1. Tissue factor exposing microparticles in inflammatory bowel disease.
    Palkovits J; Novacek G; Kollars M; Hron G; Osterode W; Quehenberger P; Kyrle PA; Vogelsang H; Reinisch W; Papay P; Weltermann A
    J Crohns Colitis; 2013 Apr; 7(3):222-9. PubMed ID: 22705067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer.
    Hron G; Kollars M; Weber H; Sagaster V; Quehenberger P; Eichinger S; Kyrle PA; Weltermann A
    Thromb Haemost; 2007 Jan; 97(1):119-23. PubMed ID: 17200778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
    Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
    Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy.
    Wang GH; Lu J; Ma KL; Zhang Y; Hu ZB; Chen PP; Lu CC; Zhang XL; Liu BC
    J Atheroscler Thromb; 2019 Jun; 26(6):538-546. PubMed ID: 30429407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation.
    Deutschmann A; Schlagenhauf A; Leschnik B; Hoffmann KM; Hauer A; Muntean W
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):401-7. PubMed ID: 23164759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease.
    He Z; Si Y; Jiang T; Ma R; Zhang Y; Cao M; Li T; Yao Z; Zhao L; Fang S; Yu B; Dong Z; Thatte HS; Bi Y; Kou J; Yang S; Piao D; Hao L; Zhou J; Shi J
    Thromb Haemost; 2016 Apr; 115(4):738-51. PubMed ID: 26660948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
    Zhao L; Bi Y; Kou J; Shi J; Piao D
    J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
    Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
    Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Procoagulant Activity of Microparticles and the Protein Z System in Patients Undergoing Off-Pump Coronary Artery Bypass Surgery.
    Słomka A; Piekuś A; Kowalewski M; Pawliszak W; Anisimowicz L; Żekanowska E
    Angiology; 2018 Apr; 69(4):347-357. PubMed ID: 28464697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.
    Hellum M; Øvstebø R; Brusletto BS; Berg JP; Brandtzaeg P; Henriksson CE
    Thromb Res; 2014 Mar; 133(3):507-14. PubMed ID: 24423888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
    Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
    Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
    Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
    Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-factor-bearing microparticles (MPs-TF) in patients with acute ischaemic stroke: the influence of stroke treatment on MPs-TF generation.
    Świtońska M; Słomka A; Sinkiewicz W; Żekanowska E
    Eur J Neurol; 2015 Feb; 22(2):395-401, e28-9. PubMed ID: 25370815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
    Woei-A-Jin FJ; van der Starre WE; Tesselaar ME; Garcia Rodriguez P; van Nieuwkoop C; Bertina RM; van Dissel JT; Osanto S
    Thromb Res; 2014 May; 133(5):799-803. PubMed ID: 24657035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.